Wordt geladen...
Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?
Hyperlipidemia is a powerful risk factor for coronary heart disease (CHD). It has been known for a long time that lipid-lowering drugs significantly reduce morbidity from CHD, thus proving a causal role for cholesterol in coronary events. Conversely, the relationship between low-density lipoprotein...
Bewaard in:
| Gepubliceerd in: | J Clin Med |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7926692/ https://ncbi.nlm.nih.gov/pubmed/33671688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040886 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|